Estrogen Receptor Positive Tumor
1 competing product in clinical development for Estrogen Receptor Positive Tumor.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eribulin mesylate + capecitabine | Eisai | Phase 2 | Completed | 35 |